Episode 37
E37: Errik Anderson on Co-Founding 20 Biotech Startups Cumulatively Worth $10B+
How I Invest with David Weisburd
January 30, 20241h 1m
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Errik Anderson sits down with David Weisburd to discuss Pro-noia, the potential of the biotech industry, and the 82VS Seed Fund investment approach. They discuss practicing Pro-noia, the value of building a portfolio of relationships, and the idea of a forever company.
(0:00) Introduction to Errik Anderson and his concept of Pro Noya
(10:22) The potential scale of platform building in the biotech industry
(20:22) Leading with work and following with capital - the approach at 82VS Seed Fund
(28:13) Practicing Pro Noya: Cultivating optimism and generosity
(33:35) Building a portfolio of relationships and the compounding value
(40:01) Errik Anderson on involving his family in his work
(46:00) Errik Anderson's management style: micro-managing or detailed involvement?
(54:09) Errik Anderson explains the concept of a forever company
(57:00) Collaborating with big pharmaceutical companies like Pfizer
(1:00:56) Launch of the Tenex Capital Podcast newsletter powered by Carrie Alabs